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The Editorial on the Research Topic
Ionotropic Glutamate Receptors Trafficking in Health and Disease
Because of their fundamental role in excitatory synaptic function in health and disease, ionotropic
glutamate receptors (iGluRs) continue to be the focus of wide-spread research efforts within the
neuroscience community.
A core aspect of on-going research is the elucidation of the complex sequence of events that
coordinate iGluR processing, delivery to, retention at, recycling, and removal from synapses
(collectively known as receptor trafficking). Understanding of the activity dependent regulation
of these events in healthy and diseased neurons will likely provide new targets for therapeutic
intervention and, we believe, holds tremendous promise for new and improved treatments for
neurological and neurodegenerative diseases.
The contributors to this special issue “Ionotropic glutamate receptors trafficking in health
and disease” each provide new insights into different aspects of this complex problem, covering
a wide range of issues, starting with early stages of trafficking taking place in the ER, through
the distribution of receptors along actin tracks to the final stages of insertion into the surface
membrane. Taken together with broader overviews, these papers provide a broad picture of current
understanding of how postsynaptic iGluRs are integral to the initiation and expression of synaptic
plasticity and how this impacts on disease.
With respect to NMDAR subunits, specific sections have been shown to affect the transition
between individual steps in receptor trafficking, including their processing and eventual release
from the ER. Based on their structure, different rules may apply to individual subunits and it is now
shown that specific structural features of GluN2C can also regulate this process (Lichnerova et al.).
On a wider scale, the processes surrounding the ER-related events in NMDAR trafficking are also
covered by a dedicated article in our special issue (Horak et al.).
Beyond their regulation at the level of transcription and translation, iGluRs are subject
to stringent regulation by post-translational modifications. Among these, the phosphorylation
of GluN2A at Ser1048 by the Dual specificity tyrosine-phosphorylation-regulated kinase 1A
(DYRK1A) can interfere with the internalization of GluN1/GluN2A NMDARs, while also
potentiating their activation and increasing the NMDAR-current density (Grau et al.).
The complexity of excitatory synapses is enhanced by AMPAR- and NMDAR-interacting
proteins. These interactions can be prolonged or transient and have profound effects on trafficking.
For example, carnitine palmitoyltransferase 1C (CPT1C) affects early steps of AMPAR trafficking
to control AMPAR availability at synapses (Gratacòs-Batlle et al.).
Another intriguing phase of AMPAR trafficking is their forward transport along tracks provided
by rapidly changing actin cytoskeleton. This occurs with the participation of various interacting
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proteins including PICK1 and the ARP2/3 Complex,
ADF/Cofilin, as well as molecular motors, such as myosin.
All of these interactors have the ability to modify trafficking of
AMPARs, thus determining both the basal synaptic transmission,
as well as activity-dependent regulation of synaptic strength
(Hanley). Once that the receptors reach their targeted surface
membrane, they need to be inserted in it and this regulated
process, mediated by SNARE proteins, is critical for the
postsynaptic expression of various forms of plasticity, as
reviewed by Jurado and Chater and Goda.
An emerging concept is that iGluRs interact with other
neurotransmitter systems and their receptors, including GABAB
(Kantamneni), nicotinic receptors (Zappettini et al.), as well
as dopaminergic system. This crosstalk has far-reaching
implications, especially for diseases such as Parkinson’s and
Huntington’s, as well as in addiction (Gardoni and Bellone).
Needless to say, with so many roles in synaptic function,
it is clear that disturbances in iGluR trafficking give rise
to serious neurological and psychiatric diseases. Among
proteins affecting iGluR trafficking, SynGAP (and the genetic
changes affecting its expression) is now recognized as the
pathophysiological substrate for autism spectrum disorder
and this fascinating topic is reviewed within our issue
(Jeyabalan and Clement).
In conclusion, we believe that the articles presented in this
special issue represent a valuable resource that provides a clear
overview of the current state of the art of this important and
rapidly progressing field of neuroscience.
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